AGARWAL, T.; ANNAMALAI, N.; RONANKI, H. P.; BUTTY, S.; MAITI, T. K.; ARSAD, H. B. MUTANT P21 PEPTIDES COULD ACT AS AN IMPROVED CYCLIN A INHIBITORS FOR CANCER THERAPY: AN IN SILICO VALIDATION. International Journal of Pharmacy and Pharmaceutical Sciences, v. 11, n. 2, p. 59-64, 24 Dec. 2018.